• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗洞察:癌症患者心血管疾病的管理及癌症治疗的心脏并发症

Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy.

作者信息

Khakoo Aarif Y, Yeh Edward T H

机构信息

Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, TX 77030-4095, USA.

出版信息

Nat Clin Pract Oncol. 2008 Nov;5(11):655-67. doi: 10.1038/ncponc1225. Epub 2008 Sep 16.

DOI:10.1038/ncponc1225
PMID:18797437
Abstract

Cardiac disease in patients with cancer or caused by cancer therapy is a clinical problem of emerging importance. Optimum management of cardiovascular disease can mean that patients with cancer can successfully receive therapies to treat their malignancy and can reduce morbidity and mortality due to cardiovascular disease in cancer survivors. The presence of cancer and cancer-related morbidities substantially complicates the management of cardiovascular disease in cancer patients. In this Review, we discuss management strategies for cardiovascular disease in patients with cancer, focusing on the prevention and treatment of congestive heart failure and myocardial infarction.

摘要

癌症患者中或由癌症治疗引起的心脏疾病是一个日益重要的临床问题。心血管疾病的优化管理意味着癌症患者能够成功接受治疗其恶性肿瘤的疗法,并可降低癌症幸存者因心血管疾病导致的发病率和死亡率。癌症及癌症相关并发症的存在使癌症患者心血管疾病的管理变得极为复杂。在本综述中,我们讨论癌症患者心血管疾病的管理策略,重点关注充血性心力衰竭和心肌梗死的预防与治疗。

相似文献

1
Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy.治疗洞察:癌症患者心血管疾病的管理及癌症治疗的心脏并发症
Nat Clin Pract Oncol. 2008 Nov;5(11):655-67. doi: 10.1038/ncponc1225. Epub 2008 Sep 16.
2
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.钙通道阻滞剂与心血管结局:对175,634例患者的荟萃分析
J Hypertens. 2009 Jun;27(6):1136-51. doi: 10.1097/HJH.0b013e3283281254.
3
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.美国临床肿瘤学会关于成年癌症幸存者持续护理的临床证据综述:心脏和肺部迟发效应
J Clin Oncol. 2007 Sep 1;25(25):3991-4008. doi: 10.1200/JCO.2007.10.9777. Epub 2007 Jun 18.
4
The role of ACE inhibitor therapy in treating cardiovascular disease.血管紧张素转换酶抑制剂疗法在治疗心血管疾病中的作用。
Nurs Times. 2004;100(12):34-7.
5
Early breast cancer therapy and cardiovascular injury.早期乳腺癌治疗与心血管损伤。
J Am Coll Cardiol. 2007 Oct 9;50(15):1435-41. doi: 10.1016/j.jacc.2007.06.037. Epub 2007 Sep 24.
6
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.预防蒽环类药物引起的心肌损伤:最具前景策略的综述
Br J Haematol. 2005 Dec;131(5):561-78. doi: 10.1111/j.1365-2141.2005.05759.x.
7
Blocking the renin-angiotensin system: dual- versus mono-therapy.阻断肾素-血管紧张素系统:双重治疗与单一治疗对比
Expert Rev Cardiovasc Ther. 2009 Jun;7(6):667-74. doi: 10.1586/erc.09.47.
8
[The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].[血管紧张素转换酶抑制剂在对抗心血管疾病中的漫长历程]
Ital Heart J. 2005 Nov;6 Suppl 7:3S-4S.
9
Preventing vascular events due to elevated blood pressure.预防因血压升高导致的血管事件。
Circulation. 2006 May 9;113(18):2166-8. doi: 10.1161/CIRCULATIONAHA.106.620757.
10
Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.已确诊高血压患者的血压控制与药物治疗:一项意大利全科医疗调查
J Hum Hypertens. 2009 Nov;23(11):758-63. doi: 10.1038/jhh.2009.14. Epub 2009 Feb 26.

引用本文的文献

1
CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer.CD74-AKT轴是三阴性乳腺癌的一个潜在治疗靶点。
Biology (Basel). 2024 Jun 28;13(7):481. doi: 10.3390/biology13070481.
2
Recommendations for broadening eligibility criteria in esophagus cancer clinical trials: the mortality disparity of esophagus cancer as a first or second primary malignancy.食管癌临床试验中扩大纳入标准的建议:食管癌作为第一或第二原发性恶性肿瘤的死亡率差异
J Thorac Dis. 2024 Jun 30;16(6):3882-3896. doi: 10.21037/jtd-23-1881. Epub 2024 Jun 24.
3
Chest Pain in the Cancer Patient.
癌症患者的胸痛
Eur Cardiol. 2022 May 31;17:e15. doi: 10.15420/ecr.2021.45. eCollection 2022 Feb.
4
Perturbations of Adjuvant Chemotherapy on Cardiovascular Responses and Exercise Tolerance in Patients with Early-Stage Breast Cancer.辅助化疗对早期乳腺癌患者心血管反应及运动耐量的影响
Biology (Basel). 2021 Sep 13;10(9):910. doi: 10.3390/biology10090910.
5
Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype.G 蛋白偶联受体靶向药物对癌症表型的非预期作用。
Trends Pharmacol Sci. 2020 Dec;41(12):1006-1022. doi: 10.1016/j.tips.2020.10.001. Epub 2020 Oct 22.
6
Cardiovascular and Cancer Risk: The Role of Cardio-oncology.心血管与癌症风险:心脏肿瘤学的作用。
J Adv Pract Oncol. 2018 Mar;9(2):160-176. Epub 2018 Mar 1.
7
Acute Coronary Syndrome Management in Cancer Patients.急性冠状动脉综合征管理在癌症患者中。
Curr Oncol Rep. 2018 Aug 22;20(10):78. doi: 10.1007/s11912-018-0724-8.
8
Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity.患有多种疾病的个体中癌症死亡率和心血管事件的竞争风险。
J Comorb. 2014 Aug 18;4:29-36. doi: 10.15256/joc.2014.4.41. eCollection 2014.
9
The Yale Fitness Intervention Trial in female cancer survivors: Cardiovascular and physiological outcomes.耶鲁女性癌症幸存者健身干预试验:心血管和生理结果。
Heart Lung. 2017 Sep-Oct;46(5):375-381. doi: 10.1016/j.hrtlng.2017.06.001. Epub 2017 Aug 10.
10
Lung cancer as a cardiotoxic state: a review.肺癌作为一种心脏毒性状态:综述。
Med Oncol. 2017 Aug 9;34(9):159. doi: 10.1007/s12032-017-1012-4.